MS Resources: Rethink Multiple Sclerosis Relapses

Multiple Sclerosis (MS) Resources

Can Do Multiple Sclerosis

A national nonprofit organization that provides innovative lifestyle empowerment programs for people with MS and their support partners.

The Consortium of Multiple Sclerosis Centers

A professional organization for MS healthcare providers and researchers in North America.

International Organization of MS Nurses

An international organization focusing on the needs of nurses involved with MS care, education, research, and advocacy.

Multiple Sclerosis Association of America

A national nonprofit organization dedicated to enriching the quality of life for people affected by MS.

Download My MS Manager smartphone app from the MSAA

A free self-care application for the MS community from the Multiple Sclerosis Association of America.

Multiple Sclerosis Foundation

A national nonprofit organization that helps people with MS maintain their health and well-being through programming and support to keep them self-sufficient.

Multiple Sclerosis International Federation

An international nonprofit established to link the activities of national MS societies around the world.

National Multiple Sclerosis Society

A national nonprofit organization with a 50-state network of chapters dedicated to funding research, advocacy, facilitating professional education, and providing programs and support for people affected by MS.


A.D.A.M. Medical Encyclopedia. Multiple sclerosis. Accessed October 4, 2012.

Achiron A, Gabbay U, Gilad R, et al. Intravenous immunoglobulin treatment in multiple sclerosis. Neurology. 1998;50:398-402.

American Academy of Neurology. Assessment of Plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;47:840-843.

American Association of Neuroscience Nurses-Association of Rehabilitation Nurses. Nursing Management of the Patient with Multiple Sclerosis. AANN and ARN Clinical Practice Guideline Series. Updated 2011. Accessed January 10, 2013.

Artemiadis AK, Anagnostouli MC, Alexopoulos EC. Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiol. 2011;36:109-120.

Brodkey MB, Ben-Zacharia AB, Reardon JD. Living well with multiple sclerosis. Am J Nurs. 2011;111:40-48.

Catania A. The melanocortin system in leukocyte biology. J Leukoc Biol. 2007;81:383-392.

Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;76:294-300.

Encyclopedia Britannica online. Brain. Accessed November 9, 2012.

Encyclopedia Britannica online. The nerve cell. Accessed November 9, 2012.

Houghton Mifflin Company. The American Heritage Medical Dictionary.'s+phenomenon. Accessed November 7, 2012.

Katz U, Kishner I, Magalashvili D, Shoenfeld Y, Achiron A. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience. Autoimmunity. 2006;39:513-517.

Köpke S, Heesen C, Kasper J, Mühlhauser I. Steroid treatment for relapses in multiple sclerosis – the evidence urges shared decision-making. Acta Neurol Scand. 2004;110:1-5.

MacLean R. Multiple sclerosis: understanding a complex neurological condition. Nursing Standard. 2010;24:50-56.

Merriam-Webster Online Medical Dictionary. Accessed November 8, 2012.

Merriam-Webster Word Central. Accessed November 8, 2012.

National Clinical Advisory Board of the National Multiple Sclerosis Society. Changing therapy in relapsing multiple sclerosis: considerations and recommendations of a Task Force of the National Multiple Sclerosis Society. Expert Opinion Paper: Treatment Recommendations for Physicians. Updated 2004. Accessed January 11, 2013.

National Institutes of Neurological Disorders and Stroke. Multiple sclerosis: hope through research. Accessed October 4, 2012.

Nicholas R, Giannetti P, Alsanousi A, Friede E, Muraro PA. Development of oral immunomodulatory agents in the management of multiple sclerosis. Drug Des Devel Ther. 2011;5:255-274.

Oliver BJ. Primary care management of fatigue and relapses in RRMS. The Nurse Pract. 2009;34:10-14.

Rejdak K, Jackson S, Giovannoni G. Multiple sclerosis: a practical overview for clinicians. Br Med Bullet. 2010;95:79-104.

Rolak LA. National Multiple Sclerosis Society. The basic facts: the history of MS. Updated 2009.Accessed November 8, 2012.

Ross AP, Halper J, Harris CJ. Assessing relapsing and response to relapse treatment in patients with multiple sclerosis. A nursing perspective. [Consensus Statement] Int J MS Care. 2012;14:148-159.

Schapiro RT. Managing the Symptoms of Multiple Sclerosis. 5th ed. New York, NY: Demos Medical Publishing LLC; 2007.

Thompson HJ, Mauk KL, Ross AP, et al. Nursing management of the patient with multiple sclerosis. AANN and ARN Clinical Practice Guidelines Series. Accessed October 8, 2012.

Thrower BW. Relapse management in multiple sclerosis. Neurologist. 2009;15:1-5.

U.S. National Institutes of Health. search engine. Updated January 11, 2013. Accessed January 11, 2013.

Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46:878-886.

Zindler E, Zipp F. Neuronal injury in chronic CNS inflammation. Best Pract Res Clin Anaesthesiol. 2010;24:551-562.